IDEXX Laboratories Inc. (IDXX)

IDEXX Laboratories Inc. (IDXX $580.11)
- $580.11 P/E (TTM): 44.88X Cap: $45.89B
- View IDXX Profile
- View Questions on IDXX

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Intuitive Surgical Inc. (ISRG $480.29)
- $480.29 P/E (TTM): 61.34X Cap: $169.65B
- View ISRG Profile
- View Questions on ISRG
Vertex Pharmaceuticals Incorporated (VRTX $453.04)
- $453.04 P/E (TTM): 30.25X Cap: $114.71B
- View VRTX Profile
- View Questions on VRTX
AbbVie Inc. (ABBV $208.71)
- $208.71 P/E (TTM): 93.12X Cap: $368.38B
- View ABBV Profile
- View Questions on ABBV
Johnson & Johnson (JNJ $238.07)
- $238.07 P/E (TTM): 21.59X Cap: $571.51B
- View JNJ Profile
- View Questions on JNJ
Eli Lilly and Company (LLY $919.56)
- $919.56 P/E (TTM): 40.54X Cap: $867.39B
- View LLY Profile
- View Questions on LLY
Merck & Company Inc. (MRK $114.62)
- $114.62 P/E (TTM): 15.92X Cap: $283.08B
- View MRK Profile
- View Questions on MRK
iShares Biotechnology ETF (IBB $163.92)
- $163.92 P/E (TTM): 20.63X Cap: $7.90B
- View IBB Profile
- View Questions on IBB
IDEXX Laboratories Inc. (IDXX $580.11)
- $580.11 P/E (TTM): 44.88X Cap: $45.89B
- View IDXX Profile
- View Questions on IDXX
Halozyme Therapeutics Inc. (HALO $64.10)
- $64.10 P/E (TTM): 25.74X Cap: $7.51B
- View HALO Profile
- View Questions on HALO
Incyte Corporation (INCY $92.71)
- $92.71 P/E (TTM): 14.7X Cap: $18.35B
- View INCY Profile
- View Questions on INCY
Catalyst Pharmaceuticals Inc. (CPRX $22.64)
- $22.64 P/E (TTM): 13.8X Cap: $2.78B
- View CPRX Profile
- View Questions on CPRX
Gilead Sciences CDR (CAD Hedged) (GILD $28.66)
- $28.66 P/E (TTM): 380.0X Cap: $245.38B
- View GILD Profile
- View Questions on GILD

Q: We have accumulated 11 healthcare stocks and 1 ETF, While LLY and ISRG are at half positions the rest are at initial 25% positions. Please advise [help!] us get to a more concentrated portfolio with a 3+ year horizon for reasonable opportunities in healthcare

Read Answer Asked by sam on January 13, 2026

Adobe Inc. (ADBE $249.96)
- $249.96 P/E (TTM): 15.22X Cap: $100.98B
- View ADBE Profile
- View Questions on ADBE
Accenture plc (ACN $200.85)
- $200.85 P/E (TTM): 16.42X Cap: $128.88B
- View ACN Profile
- View Questions on ACN
Nike Inc. (NKE $53.23)
- $53.23 P/E (TTM): 32.42X Cap: $79.15B
- View NKE Profile
- View Questions on NKE
Thermo Fisher Scientific Inc (TMO $463.55)
- $463.55 P/E (TTM): 26.65X Cap: $172.62B
- View TMO Profile
- View Questions on TMO
TELUS Corporation (T $18.16)
- $18.16 P/E (TTM): 25.53X Cap: $28.51B
- View T Profile
- View Questions on T
IDEXX Laboratories Inc. (IDXX $580.11)
- $580.11 P/E (TTM): 44.88X Cap: $45.89B
- View IDXX Profile
- View Questions on IDXX

Q: Dear 5i,

I have a diverse portfolio with stocks and ETFs. Most of my portfolio is doing well. Want to know your thoughts about a few of my holdings that are not doing so well - Adobe, Nike, Accenture, TMO, IDXX and Telus.

What are your thoughts? Should I replace these with a US ETF or hold on. Thanks for your valuable advice as always.

Read Answer Asked by Alka on November 26, 2025

IDEXX Laboratories Inc. (IDXX $580.11)
- $580.11 P/E (TTM): 44.88X Cap: $45.89B
- View IDXX Profile
- View Questions on IDXX

Q: I bought half a position in IDEXX about a month ago, they recently had about a 25% pop after their results. Would you be comfortable for me adding to my position here?

Read Answer Asked by Andrew on August 11, 2025